Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN13869986) titled 'Developing immersive virtual exposures for obsessive-compulsive disorder' on Dec. 29, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Champalimaud Foundation
Condition:
Obsessive-Compulsive Disorder
Mental and Behavioural Disorders
Intervention:
3 Arms:
AI-generated OCD immersive VR exposure
AI-generated OCD-related exposure via widescreen display
Neutral immersive VR exposure (control)
Arm 1: AI-generated OCD-related immersive VR exposure
Participants receive ...